Keying Zhu

Karolinska University Hospital

Papers

1

Total Citations

65

H-Index

1

About

Keying Zhu is a pioneering researcher at the intersection of DNA nanotechnology and synthetic biology, whose work focuses on engineering intelligent molecular systems for targeted cancer therapy. Their most significant contribution to date is the development of a DNA robotic switch that can autonomously display cytotoxic ligand nanopatterns in response to specific stimuli. This groundbreaking approach, detailed in their 2024 paper which has already garnered 65 citations, addresses a critical challenge in cancer treatment: how to selectively activate death receptors on tumor cells while sparing healthy tissue. By creating a stimuli-responsive molecular robot that clusters death receptors only in the presence of cancer-associated signals, Zhu has opened new avenues for precision medicine that could dramatically reduce the side effects of conventional chemotherapy. Their work represents a masterful fusion of DNA origami, dynamic nanotechnology, and cell biology, demonstrating how programmable molecular machines can be designed to sense their environment and execute therapeutic actions with remarkable specificity. This innovative strategy has positioned Zhu as a rising leader in the field of smart drug delivery systems and synthetic biology.

Research Focus

Key Achievements

1
H-Index
1
Papers
65
Total Citations
65
Avg Citations/Paper
🏆 Most Cited Paper
A DNA robotic switch with regulated autonomous display of cytotoxic ligand nanopatterns
65 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Karolinska University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago